A new condom aimed at helping men who have trouble in maintaining an erection is nearing final regulatory approval in Europe.
Dubbed as 'Viagra' condom, the new erection-enhancing product was developed by British biotech company Futura Medical and licensed to the maker of Durex condoms.
The condom, currently known as CSD500, will include a vasodilator gel that increases blood flow and results in a stronger, longer-lasting erection, reports the Independent.
Durex had announced late last month its aim to unroll the condoms in Europe by the end of the year.
Plans have yet to be announced on whether the manufacturers will apply for FDA approval to market the condoms in the U.S.
Research has shown that men who struggle with maintaining erections while wearing condoms are less likely to use them and more likely to risk unprotected sex.
Adam Glickman, founder of the online store Condomania.com, said in an interview with Portfolio magazine that the new condom might encourage these men to start changing their ways and practicing safe sex.